WallStreetZenWallStreetZen

NASDAQ: AIRS
Airsculpt Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AIRS

Based on 1 analyst offering 12 month price targets for Airsculpt Technologies Inc

Min Forecast
$2.50-59.94%
Avg Forecast
$2.50-59.94%
Max Forecast
$2.50-59.94%

Should I buy or sell AIRS stock?

Based on 1 analyst offering ratings for Airsculpt Technologies Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their AIRS stock forecasts and price targets.

AIRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-31

1 of 1

Forecast return on equity

Is AIRS forecast to generate an efficient return?

Company
N/A
Industry
-99.11%
Market
-46.52%

Forecast return on assets

Is AIRS forecast to generate an efficient return on assets?

Company
N/A
Industry
10.83%

AIRS earnings per share forecast

What is AIRS's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.08
Avg 2 year Forecast
$0.00
Avg 3 year Forecast
$0.00

AIRS revenue forecast

What is AIRS's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$162.9M-1.32%
Avg 2 year Forecast
$170.3M+3.13%
Avg 3 year Forecast
$185.6M+12.4%
AIRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AIRS revenue growth forecast

How is AIRS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
3.72%
Industry
4.44%
Market
10.99%
AIRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AIRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AIRS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
AIRS$6.24$2.50-59.94%Hold
CYH$2.73$3.58+30.95%Hold
EHAB$7.39$8.50+15.02%Hold
CMPS$4.24$18.00+324.53%Strong Buy
CCRN$13.01$17.56+34.93%Hold
View Top Medical Care Facility Stocks

Airsculpt Technologies Stock Forecast FAQ

Is Airsculpt Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AIRS) stock is to Hold AIRS stock.

Out of 1 analyst, 0 (0%) are recommending AIRS as a Strong Buy, 0 (0%) are recommending AIRS as a Buy, 1 (100%) are recommending AIRS as a Hold, 0 (0%) are recommending AIRS as a Sell, and 0 (0%) are recommending AIRS as a Strong Sell.

If you're new to stock investing, here's how to buy Airsculpt Technologies stock.

What is AIRS's earnings growth forecast for 2025-2027?

(NASDAQ: AIRS) Airsculpt Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 10.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Airsculpt Technologies's earnings in 2025 is -$14,512,000.On average, 1 Wall Street analyst forecast AIRS's earnings for 2025 to be -$4,994,934, with the lowest AIRS earnings forecast at -$4,994,934, and the highest AIRS earnings forecast at -$4,994,934. On average, 1 Wall Street analyst forecast AIRS's earnings for 2026 to be $0, with the lowest AIRS earnings forecast at $0, and the highest AIRS earnings forecast at $0.

In 2027, AIRS is forecast to generate $0 in earnings, with the lowest earnings forecast at $0 and the highest earnings forecast at $0.

What is AIRS's revenue growth forecast for 2025-2027?

(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 3.72% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.99%.

Airsculpt Technologies's revenue in 2025 is $165,109,000.On average, 2 Wall Street analysts forecast AIRS's revenue for 2025 to be $10,172,494,460, with the lowest AIRS revenue forecast at $10,096,009,539, and the highest AIRS revenue forecast at $10,248,979,381. On average, 2 Wall Street analysts forecast AIRS's revenue for 2026 to be $10,631,403,984, with the lowest AIRS revenue forecast at $10,598,624,733, and the highest AIRS revenue forecast at $10,664,183,236.

In 2027, AIRS is forecast to generate $11,586,685,035 in revenue, with the lowest revenue forecast at $11,247,966,101 and the highest revenue forecast at $11,925,403,970.

What is AIRS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AIRS) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 10.83%.

What is AIRS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AIRS price target, the average AIRS price target is $2.50, with the highest AIRS stock price forecast at $2.50 and the lowest AIRS stock price forecast at $2.50.

The Wall Street analyst predicted that Airsculpt Technologies's share price could fall to $2.50 by Mar 31, 2026. The average Airsculpt Technologies stock price prediction forecasts a potential downside of 59.94% from the current AIRS share price of $6.24.

What is AIRS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AIRS) Airsculpt Technologies's current Earnings Per Share (EPS) is -$0.24. On average, analysts forecast that AIRS's EPS will be -$0.08 for 2025, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at -$0.08. On average, analysts forecast that AIRS's EPS will be $0.00 for 2026, with the lowest EPS forecast at $0.00, and the highest EPS forecast at $0.00. In 2027, AIRS's EPS is forecast to hit $0.00 (min: $0.00, max: $0.00).

What is AIRS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AIRS) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.